Draghia-Akli Ruxandra sold NVAX
March 3, 2026 · Form 4 insider transaction
Draghia-Akli Ruxandra sold 26,667 shares of Novavax, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
26,667
Price
$0.00
Total value
N/A
InsiderDraghia-Akli Ruxandra
RoleOfficer
CompanyNovavax, Inc. (NVAX)
SecurityRestricted Stock Units
Transaction codeD: Disposition to the issuer
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after53,333
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date.